1. Home
  2. NYAX vs MNKD Comparison

NYAX vs MNKD Comparison

Compare NYAX & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nayax Ltd.

NYAX

Nayax Ltd.

HOLD

Current Price

$51.30

Market Cap

2.1B

Sector

N/A

ML Signal

HOLD

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$3.26

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NYAX
MNKD
Founded
2005
1991
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.7B
IPO Year
2022
2004

Fundamental Metrics

Financial Performance
Metric
NYAX
MNKD
Price
$51.30
$3.26
Analyst Decision
Buy
Strong Buy
Analyst Count
5
6
Target Price
$47.50
$10.08
AVG Volume (30 Days)
10.9K
4.3M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
350.00
EPS
N/A
0.07
Revenue
N/A
$285,504,000.00
Revenue This Year
$29.95
$21.29
Revenue Next Year
$23.27
$25.53
P/E Ratio
$89.78
$49.71
Revenue Growth
N/A
43.50
52 Week Low
$32.38
$3.29
52 Week High
$60.77
$6.51

Technical Indicators

Market Signals
Indicator
NYAX
MNKD
Relative Strength Index (RSI) 38.43 18.11
Support Level $51.24 N/A
Resistance Level $52.46 $6.08
Average True Range (ATR) 1.56 0.39
MACD -0.84 -0.24
Stochastic Oscillator 10.24 10.27

Price Performance

Historical Comparison
NYAX
MNKD

About NYAX Nayax Ltd.

Nayax Ltd is an end-to-end retail technology platform for unattended commerce. It provides consumers with digital, cashless payments, and connected commerce experiences, enhancing consumer conversion and loyalty. Its platform addresses the entire unattended commerce value chain, including a payments infrastructure, a commerce software suite, a consumer engagement platform, and integrated POS devices. The company addresses a broad range of retail verticals, including all types of vending machines, coffee machines, unattended checkout counters, self-service kiosks, ticketing machines, car wash stations, gaming machines, amusement rides, laundromats, EV charging stations, and many more.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: